Valuation Synlogic, Inc.

Stocks

Market Closed - OTC Markets 19:40:29 21/08/2026 +04			5-day change	1st Jan Change
1.200 ^USD	-1.64%		-1.64%	+7.14%

08-12	Synlogic, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Caldera Therapeutics, Inc. entered into an agreement and plan of merger to acquire Synlogic, Inc. for an enterprise value of approximately $500 million in a reverse merger transaction.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	75.24	168.7	53.6	35.38	16.37	13.1
Change	-	124.21%	-68.23%	-33.99%	-53.72%	-19.98%
Enterprise Value (EV) ¹	-2.397	52.66	-3.736	4.908	-2.485	-1.565
Change	-	2,296.5%	-107.09%	231.38%	-150.64%	37.02%
P/E	-1.31x	-2.21x	-0.82x	-0.44x	-0.73x	-13.7x
PBR	0.72x	1.15x	0.61x	0.83x	1.28x	1.1x
PEG	-	0.1x	0.1x	0x	0x	0.1x
Capitalization / Revenue	138x	96.2x	45.4x	10.5x	2,047x	-
EV / Revenue	-4.4x	30x	-3.17x	1.46x	-311x	-
EV / EBITDA	0.04x	-0.9x	0.06x	-0.09x	0.16x	0.49x
EV / EBIT	0.04x	-0.87x	0.06x	-0.09x	0.16x	0.44x
EV / FCF	0.09x	-1.75x	0.11x	-0.22x	0.1x	0.29x
FCF Yield	1,054%	-57.1%	885%	-454%	1,042%	345%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-24.77	-16.42	-13.83	-8.81	-1.915	-0.0816
Distribution rate	-	-	-	-	-	-
Net sales ¹	0.545	1.754	1.18	3.371	0.008	-
EBITDA ¹	-57.83	-58.32	-64.9	-53.2	-15.43	-3.185
EBIT ¹	-60.47	-60.76	-67.42	-55.16	-15.78	-3.532
Net income ¹	-59.17	-60.56	-66.15	-57.28	-23.36	-1.005
Net Debt ¹	-77.64	-116	-57.33	-30.47	-18.86	-14.67
Reference price ²	32.400	36.300	11.400	3.850	1.400	1.120
Nbr of stocks (in thousands)	2,322	4,647	4,701	9,189	11,696	11,699
Announcement Date	25/03/21	17/03/22	29/03/23	19/03/24	06/03/25	12/03/26

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
SYNLOGIC, INC.	-	-	-	-	14.04M
LONZA GROUP AG	34.78x	6.2x	18.42x	0.92%	51.61B
REVOLUTION MEDICINES, INC.	-21.47x	297.59x	-22.09x	-.--%	44.89B
IQVIA HOLDINGS INC.	33.46x	3.25x	14.02x	-.--%	42.77B
BEONE MEDICINES AG	49.05x	5.7x	31.17x	-.--%	42.58B
CELLTRION, INC.	29.21x	8.45x	21.35x	0.39%	31.82B
MEDPACE HOLDINGS, INC.	35.3x	5.79x	26.33x	-.--%	17.33B
EUROFINS SCIENTIFIC SE	24.28x	2.11x	9.13x	1.11%	14.76B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	78.97x	4.14x	16.07x	-.--%	14.09B
Average	32.95x	41.65x	14.30x	0.3%	28.87B
Weighted average by Cap.	28.33x	55.88x	13.02x	0.29%